By inhibiting the tyrosinase activity, azelaic acid diminishes the formation of aberrant melanocytes, and it also has anti-inflammatory characteristics, making it an appealing alternative for melasma therapy [21-23] because the inflammatory cells and inflammation play a crucial role in the pathogenesis of melasma [37,38]. This evidence concerns the gene TYR and freckles.